Maggot Debridement Market size is estimated to be $9.63 million in 2019, growing at a CAGR of 8.7% during the forecast period 2020-2025.
Maggot Debridement is a form of therapeutic wound treatment in which sterile or disinfected larvae of certain blowfly species are used to remove non-vitalized tissue, pus, slough and metabolic waste on the wound and promote healing.
Maggot Debridement is also known as maggot therapy, bio debridement, larval therapy, biosurgery, biotherapy and bio surgical debridement.
Moreover, maggot debridement is a safe, effective and controlled method of healing chronic wounds by debridement and disinfection.
Growing geriatric population, changing lifestyle, wrong eating habits, chronic illness leading to diabetes are some of the key factors driving the maggot debridement market in the upcoming years.
Moreover, according to World Health Organization in 2016 an estimated 1.6million deaths were directly caused by diabetes and between 2000 and 2016, there was a 5% increase in premature mortality from diabetes.